Neo Medical, a Lausanne, Switzerland-based company that specializes in spine surgery, raised up to $68M in Equity funding.
The round was led by Gyrus Capital, with participation from existing investors, including founders Vincent Lefauconnier and Jonas Larsson.
The company intends to use the funds to increase its market share in key regions with an immediate focus on expanding the US business, deploying new products, and enhancing the capabilities of its AI-driven augmented reality intraoperative data platform, ADVISE™.
Led by Vincent Lefauconnier and Jonas Larsson, Neo Medical is a company combining biomechanics and intraoperative augmented reality to set new standards in spine fusion surgery. Designed to support treatment of any operable thoracolumbar condition in a single procedural platform, its portfolio integrates proprietary force control technologies with intraoperative, AI-driven augmented reality data capabilities to improve patient outcomes, reduce environmental impacts, and lower healthcare-associated costs.
Since commercial launch in 2016, Neo’s technologies have been used to treat around 36,000 patients, with the company making significant progress in both operational and clinical performance compared to traditional standards.
Based near Lausanne, Switzerland, Neo Medical has operating subsidiaries in the US, Spain, France, and Germany. In addition to the lead investor Gyrus, its shareholding base includes institutional players such as Swisscom Ventures, Verve Ventures, 4FO, and Credit Suisse Entrepreneur Capital.
FinSMEs
17/09/2024